![](/images/png/glyphicons-368-expand.png)
![](/images/png/glyphicons-791-one-day.png)
[ Fri, Feb 10th 2012
] - Market Wire
[ Fri, Feb 10th 2012
] - WOPRAI
[ Fri, Feb 10th 2012
] - WOPRAI
[ Fri, Feb 10th 2012
] - WOPRAI
[ Fri, Feb 10th 2012
] - WOPRAI
[ Fri, Feb 10th 2012
] - WOPRAI
[ Fri, Feb 10th 2012
] - WOPRAI
[ Fri, Feb 10th 2012
] - WOPRAI
[ Fri, Feb 10th 2012
] - WOPRAI
[ Fri, Feb 10th 2012
] - Market Wire
[ Fri, Feb 10th 2012
] - Market Wire
[ Fri, Feb 10th 2012
] - Market Wire
[ Fri, Feb 10th 2012
] - WOPRAI
[ Fri, Feb 10th 2012
] - WOPRAI
[ Fri, Feb 10th 2012
] - WOPRAI
[ Fri, Feb 10th 2012
] - WOPRAI
[ Fri, Feb 10th 2012
] - WOPRAI
[ Fri, Feb 10th 2012
] - WOPRAI
[ Fri, Feb 10th 2012
] - WOPRAI
[ Fri, Feb 10th 2012
] - WOPRAI
[ Fri, Feb 10th 2012
] - WOPRAI
[ Fri, Feb 10th 2012
] - WOPRAI
[ Fri, Feb 10th 2012
] - WOPRAI
[ Fri, Feb 10th 2012
] - WOPRAI
[ Fri, Feb 10th 2012
] - WOPRAI
Matthew Harrison Initiated (BIIB) at Buy and Held Target at $140 on, Feb 10th, 2012
Matthew Harrison of Morgan Stanley, Initiated "Biogen Inc." (BIIB) at Buy and Held Target at $140 on, Feb 10th, 2012.
Matthew, nor any peers, have made any analyst calls on BIIB in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources
Similar Stocks and Investing Articles
[ Thu, Feb 09th 2012
] - WOPRAI
[ Thu, Feb 09th 2012
] - WOPRAI
[ Thu, Feb 09th 2012
] - WOPRAI
[ Thu, Feb 09th 2012
] - WOPRAI
[ Thu, Feb 09th 2012
] - WOPRAI
[ Thu, Feb 09th 2012
] - WOPRAI
[ Thu, Feb 09th 2012
] - WOPRAI
[ Wed, Feb 08th 2012
] - WOPRAI
[ Wed, Feb 08th 2012
] - WOPRAI
[ Tue, Feb 07th 2012
] - WOPRAI